Additional file 1 of Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study

Hosoya, Kazutaka; Fujimoto, Daichi; Morimoto, Takeshi; Kumagai, Toru; Tamiya, Akihiro; Taniguchi, Yoshihiko; Yokoyama, Toshihide; Ishida, Tadashi; Matsumoto, Hirotaka; Hirano, Katsuya; Kominami, Ryota; Tomii, Keisuke; Suzuki, Hidekazu; Hirashima, Tomonori; Tanaka, Satoshi; Uchida, Junji; Morita, Mitsunori; Kanazu, Masaki; Mori, Masahide; Nagata, Kenji; Fukuda, Ikue; Tamiya, Motohiro

doi:10.6084/m9.figshare.14361531.v1

12885_2021_8048_MOESM1_ESM.docx (17.45 kB)

Additional file 1 of Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study

journal contribution

posted on 2021-04-02, 03:54 authored by Kazutaka Hosoya, Daichi Fujimoto, Takeshi Morimoto, Toru Kumagai, Akihiro Tamiya, Yoshihiko Taniguchi, Toshihide Yokoyama, Tadashi Ishida, Hirotaka Matsumoto, Katsuya Hirano, Ryota Kominami, Keisuke Tomii, Hidekazu Suzuki, Tomonori Hirashima, Satoshi Tanaka, Junji Uchida, Mitsunori Morita, Masaki Kanazu, Masahide Mori, Kenji Nagata, Ikue Fukuda, Motohiro Tamiya

Additional file 1.